BSE filing, NSE: PAEL. Summary written from the filing by ALFA Finder's alert engine.
Pae Ltd: key numbers
- Share price
- ₹89.62
- Market cap
- ₹11.65 Cr
- Revenue (annual)
- ₹2.53 Cr
- Net profit (annual)
- ₹0.33 Cr
- P/E (TTM)
- 14.3×Sector 30.9×
- Promoter holding
- 73.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pae Ltd
All →Aurique Other Announcement
Aurique Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with Regulation 31(1)(b).
Aurique Board Meeting Date
Aurique Limited has scheduled a board meeting for October 14, 2026, to consider and approve the unaudited standalone financial results for the quarter and half-year ended September 30, 2026.
Aurique Capital Structure Change
Aurique Ltd allotted 78,11,100 fully convertible equity warrants on a preferential basis to two allottees at an issue price of Rs. 12.00 per warrant.
- Value
- ₹9.37 Cr
Aurique Capital Structure Change
Aurique Ltd allotted 73,50,700 fully convertible equity warrants on a preferential basis at an issue price of ₹12.00 per warrant.
- Value
- ₹8.82 Cr
Aurique Capital Structure Change
Aurique Ltd allotted 98,38,200 warrants to two allottees at ₹12.00 per warrant, aggregating to ₹11.81 Crore.
- Value
- ₹11.81 Cr
Aurique Annual General Meeting
Aurique Limited conducted its Extra-Ordinary General Meeting on September 03, 2026. Shareholders considered resolutions for a preferential warrant issue, object clause changes, and a director appointment.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.